$125 Million Settlement Reached in Warner Chilcott Whistleblower Lawsuit

On October 29, 2015, pharmaceutical manufacturer Warner Chilcott agreed to plead guilty to a felony healthcare fraud scheme and to pay $125 million to resolve kickback allegations. Seeger Weiss LLP represented the two former Warner Chilcott drug sales representatives who blew the whistle and brought this historic healthcare fraud whistleblower lawsuit forward. According to the […]

October 29, 2015

health care fraud

On October 29, 2015, pharmaceutical manufacturer Warner Chilcott agreed to plead guilty to a felony healthcare fraud scheme and to pay $125 million to resolve kickback allegations. Seeger Weiss LLP represented the two former Warner Chilcott drug sales representatives who blew the whistle and brought this historic healthcare fraud whistleblower lawsuit forward.

According to the Department of Justice (DOJ), the company’s marketing scheme involved paying kickbacks to health care professionals to prescribe its drugs as well as filling out and submitting fraudulent prior authorization requests to evade Medicare and Medicaid formulary restrictions—also a violation of patients’ privacy protections under HIPAA. In addition to Warner Chilcott pleading guilty, DOJ also announced today the indictments of former company president Carl Reichel and district managers Timothy Garcia and Landon Eckles. On October 27, 2015, DOJ filed an indictment against Rita Luthra, a Massachusetts physician. In July 2015, district manager Jeffrey Podolosky also pled guilty.

“Our clients were heroic in coming forward with these allegations and assisting DOJ with its investigation,” said relators’ counsel, Seeger Weiss founding partner Stephen A. Weiss. “It’s deeply gratifying that their perseverance and dedication has resulted in these criminal indictments and the end of Warner Chilcott’s corrupt practices. They each actively cooperated with the government’s criminal investigation for many months, helping to confirm just how important and valuable the whistleblower provisions of the False Claims Act are in rooting out and bringing an end to corporate fraud.”

The civil settlement was handled by Assistant U.S. Attorneys Sonya Rao and Susan Poswistilo of Ortiz’s Civil Division and Trial Counsel Colin Huntley of the Commercial Litigation Branch of the Justice Department’s Civil Division.

Notwithstanding claims relating to this product, the drug/medical device remains approved by the U.S. FDA.

About Seeger Weiss LLP

Founded in 1999, Seeger Weiss LLP has successfully represented relators in a myriad of qui tam “whistleblower” proceedings.  A trial firm with offices in New York, New Jersey, and Philadelphia, Seeger Weiss litigates each case as if it is going to go the distance.  We are determined to level the playing field and give a voice for our clients.  The results we achieve are characteristic of our unwavering commitment to obtain justice for our clients and our belief in the system that provides for it.

Related Documents

Download Warner Chilcott Settlement Agreement
Download Carl Reichel Indictment
Download Complaint

Contact

Stephen A. Weiss
sweiss@www.seegerweiss.com
(877) 709-5531

Related News

August 22, 2025
Fifteen Seeger Weiss Attorneys Selected For Inclusion in the 2026 Edition of The Best Lawyers in America

Seeger Weiss LLP is proud to announce that 15 of its attorneys have been selected for inclusion in the 2026 edition of The Best Lawyers in America, including in the Best Lawyers: Ones to Watch in America, and Lawyer of the Year lists. These attorneys have been celebrated for their work in mass tort and […]

Read More
August 4, 2025
Lawdragon Names Five Seeger Weiss Partners to 2025 500 Leading Global Litigators List

Lawdragon has recognized five Seeger Weiss partners—Chris Seeger, Stephen Weiss, David Buchanan, Jennifer Scullion, and Parvin Aminolroaya—in their 2025 Lawdragon 500 Leading Global Litigators list. This annual guide honors lawyers who “assiduously work to resolve disputes between nations, bring justice for human rights abuses, address financial fraud that crosses borders and unearth stashed assets.” The […]

Read More
July 31, 2025
Seeger Weiss Founding Partner Christopher Seeger Appointed Plaintiffs’ Lead Negotiation Counsel in Johnson & Johnson Talcum Powder Litigation

Seeger Weiss founding partner Christopher Seeger has been appointed Plaintiffs’ Lead Negotiation Counsel in the Johnson & Johnson Talcum Powder Litigation by the Honorable Judge Rukhsanah L. Singh of the District of New Jersey. The multidistrict litigation includes nearly 60,000 pending cases of women who developed ovarian cancer after using Johnson & Johnson’s Baby Powder, […]

Read More